DE2644156A1 - Pilocarpinsalze - Google Patents

Pilocarpinsalze

Info

Publication number
DE2644156A1
DE2644156A1 DE19762644156 DE2644156A DE2644156A1 DE 2644156 A1 DE2644156 A1 DE 2644156A1 DE 19762644156 DE19762644156 DE 19762644156 DE 2644156 A DE2644156 A DE 2644156A DE 2644156 A1 DE2644156 A1 DE 2644156A1
Authority
DE
Germany
Prior art keywords
pilocarpinium
dihydroxybenzoate
acid
pilocarpine
dihydrogen phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19762644156
Other languages
German (de)
English (en)
Inventor
Ta-Jyh Lee
Robert Lawrence Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2644156A1 publication Critical patent/DE2644156A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19762644156 1975-10-08 1976-09-30 Pilocarpinsalze Ceased DE2644156A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/620,623 US4045558A (en) 1975-10-08 1975-10-08 Pilocarpine salts

Publications (1)

Publication Number Publication Date
DE2644156A1 true DE2644156A1 (de) 1977-04-21

Family

ID=24486667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762644156 Ceased DE2644156A1 (de) 1975-10-08 1976-09-30 Pilocarpinsalze

Country Status (9)

Country Link
US (1) US4045558A (enExample)
JP (1) JPS5247911A (enExample)
CH (1) CH623819A5 (enExample)
DE (1) DE2644156A1 (enExample)
DK (1) DK415676A (enExample)
FR (1) FR2326922A1 (enExample)
GB (1) GB1510939A (enExample)
NL (1) NL7610208A (enExample)
SE (1) SE427111B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69593A (en) * 1982-09-17 1988-09-30 Bundegaard Hans Pilocarpine prodrugs,their preparation and pharmaceutical compositions containing them
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
EP0707589B1 (en) * 1993-07-06 1998-10-07 Polis A.G. Process for the extraction and purification of alkaloids
JP4605726B2 (ja) * 1997-09-02 2011-01-05 日本曹達株式会社 フェノール誘導体を成分化合物とする分子化合物
US20060029665A1 (en) * 2004-08-03 2006-02-09 Transoral Pharmaceuticals, Inc. Pilocarpine compositions and methods of use thereof
RU2414193C2 (ru) * 2005-07-29 2011-03-20 Сантен Фармасьютикал Ко., Лтд. Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
CA3039125A1 (en) * 2016-10-04 2018-04-12 Cellix Bio Private Limited Compositions and methods for the treatment of xerostomia
US20250154135A1 (en) * 2022-01-29 2025-05-15 Nanjing Gritpharma Co., Ltd. M-choline receptor agonist compound, preparation method therefor and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
IL25251A (en) * 1965-07-20 1969-11-12 Merck & Co Inc Aqueous mixtures for ophthalmology based on hydroxyethylcellulose and a method for their preparation
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same

Also Published As

Publication number Publication date
DK415676A (da) 1977-04-09
SE7610218L (sv) 1977-04-09
GB1510939A (en) 1978-05-17
JPS5247911A (en) 1977-04-16
US4045558A (en) 1977-08-30
CH623819A5 (enExample) 1981-06-30
FR2326922A1 (fr) 1977-05-06
FR2326922B1 (enExample) 1979-07-20
SE427111B (sv) 1983-03-07
NL7610208A (nl) 1977-04-13

Similar Documents

Publication Publication Date Title
DE2644156A1 (de) Pilocarpinsalze
DE3751006T2 (de) Psychostimulierendes mittel.
DE69813839T2 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
CH631891A5 (en) Eye insert for the generation of artificial tears
EP0128483A2 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE2423389A1 (de) Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung
EP0173186B1 (de) Flavanonderivate
DE60218153T2 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE3424781A1 (de) Verwendung von l-carnosin zur tumorbehandlung
DE69736130T2 (de) Pharmazeutische produkte zur heilung und vorbeugung von krankheiten, die aus der beschädigung der vaskulären endothelzellen hervorgehen
DE2263126A1 (de) Durch einen cyklus mit 5 kohlenstoffatomen substituierte phenolderivate, deren herstellung und verwendung
DE1767163C3 (de) Blutdrucksenkendes Arzneimittel
DE2216892C2 (de) Wässrige Suspension zur Behandlung von otologischen und ophtalmologischen Infektionen
EP0450123B1 (de) Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung
DE2243776A1 (de) Komplexe von tetracyclinen mit tris(hydroxymethyl)-aminomethan
LU83138A1 (de) Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
DE1806926A1 (de) Lithiumsalz der Hydrochinonsulfonsaeure
DE2143570A1 (de) Pharmazeutisch wirksame Ätherverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2757431A1 (de) 5-fluoruracilderivate und mittel, die diese enthalten
DE2624918A1 (de) Arzneimittel mit antiarrhythmischer wirkung
DE2428680C2 (de) 1-(2',4',6'-Trihydroxyphenyl)-propandion-(1,2)-Verbindungen, Verfahren zu deren Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE3238726A1 (de) Phosphoramidderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DD146459A5 (de) Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate
DE3101093A1 (de) 1-phenyl-4-morpholino-but-1-en-3-ol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2724608C2 (de) 1-(4-Isopropylthiophenyl)-2-n-octylaminopropanol enthaltende pharmazeutische Zubereitung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8131 Rejection